Critical Path Public Private Partnerships Clinical Trials Optional
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Food and Drug Administration is seeking applications to renew cooperative agreement 5U18FD005320 to maintain and manage existing consortia groups established by the Critical Path Institute. This initiative is conducted under Section 566 of the Federal Food, Drug, and Cosmetic Act to support the Critical Path Initiative through collaborative research, education, and outreach projects. The primary goal is to foster drug product innovation and accelerate the development, manufacturing, and translation of therapeutics while improving safety, efficacy, quality, and performance. This forecast opportunity, categorized under NAICS code 541715, is managed by the Department of Health and Human Services. Funding for these public private partnerships is subject to the availability of FDA resources. Interested parties can coordinate with the point of contact, Terrin Brown, regarding this effort to enhance clinical trial innovation and therapeutic development.
General Info
Agency
Place of Performance
Not specifiedSet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Critical Path Initiative introduced in Section 566 of the Federal Food, Drug, and Cosmetic Act. This includes developing innovative, collaborative projects in research, education, and outreach for fostering drug product innovation, enabling the acceleration of development, manufacturing, and translational therapeutics, enhancing safety, efficacy, quality, and performance. This funding opportunity will provide support, depending on availability of FDA funding.
Similar Contracts
Same NAICS industry code
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
